Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
16.00
-0.36 (-2.20%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $172.27 million as of March 31, 2026. Its market cap has increased by 181.75% in one year.
Market Cap
172.27M
Enterprise Value
110.03M
1-Year Change
181.75%
Ranking
Category
Stock Price
$16.00
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $172.27M, a decrease of -93.13%. That is a compound annual growth rate of -36.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 172.27M | -20.60% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 709.68M |
| Personalis | 645.58M |
| Fulgent Genetics | 490.95M |
| Myriad Genetics | 405.83M |
| Prenetics Global | 327.48M |
| Biodesix | 135.75M |
| FONAR | 121.61M |
| MDxHealth | 117.37M |